High-performance Liquid Chromatography (HPLC) Market (2023-2030)
The High-performance Liquid Chromatography (HPLC) Market is projected to reach $7.9 billion by 2030, at a CAGR of 5.2% from 2023 to 2030.
- Published
- Jul 2023
- Pages
- 251
- Format
- PDF + Excel
- Report ID
- MRHC - 104711
- Base year
- 2022
- 2030 · FORECAST
- $7.90B
- 2030
- $7.90B
- CAGR 2023–2030
- 5.2%
2022 baseline · 2023–2030 forecast at 5.2% CAGR · hover a bar for the value
Key highlights
The High-performance Liquid Chromatography (HPLC) Market is projected to reach $7.9 billion by 2030, at a CAGR of 5.2% from 2023 to 2030.
The HPLC systems segment is expected to account for the largest share of the HPLC market.
In 2023, North America is expected to account for the largest share of the global HPLC market. North America’s major market share is attributed to rising investments in pharmaceutical R&D, increased sales of pharmaceuticals, stringent environmental policies for monitoring pesticide & industrial chemical degrades, well-developed research infrastructure, and the presence of key market players in the region.
Report summary
| Particulars | Details |
|---|---|
| Base Year | 2022 |
| Estimated Year | 2023 |
| Forecast Period | 2023–2030 |
| Market Size (2030) | USD 7.90 billion |
| CAGR (2023–2030) | 5.2% |
| Format | PDF, Excel & Cloud Portal · 251 pages |
| Segments Covered | By Product: HPLC Systems, Consumables Columns Pre-packed Columns, Empty Columns, Detectors & Lamps, Pumps, Fraction Collectors, Other Components & Accessories · By End User: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Food & Beverage Companies, Environmental Testing Laboratories, Hospitals & Clinics, Oil & Gas Industries, Other End Users |
| Countries Covered | North America (Canada, Mexico), Europe (Germany, France, U.K., Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Latin America (Brazil) |
| Key Companies | Waters Corporation, Shimadzu Corporation, Danaher Corporation, Bruker Corporation, Merck KGaA, Agilent Technologies, Inc., PerkinElmer, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Sartorius AG, Gilson, Inc., Tosoh Corporation, Hitachi, Ltd., JASCO Corporation |
Report overview
Segments covered: product, end user. Regions: North America, Europe, Asia-Pacific, Latin America.
High-performance liquid chromatography (HPLC) is the chromatographic process of dividing the ingredients in a mixture to purify, identify, and quantify components. HPLC has been used in multiple applications, including developing and manufacturing pharmaceutical and biological products, separating components of a complex biological sample in analytical chemistry, and detecting vitamin D levels in blood serum in clinical diagnostics.
The HPLC market covers HPLC systems, consumables, components & accessories, and software & services offered by key companies for clinical research, diagnostics, forensics and other applications for use in pharmaceutical & biopharmaceutical industries, research & academic institutes, and food & beverage industries.
Increasing R&D investments in the pharmaceutical and biotechnology industries, technological advancements in HPLC, rising food safety concerns, and stringent policies and initiatives to reduce environmental pollution drive the market’s growth. However, the high cost of HPLC instruments restrains this market's growth.
Emerging economies and the development of bio-clusters to foster research offer opportunities for market growth. However, the shortage of skilled HPLC professionals and the adoption of refurbished HPLC instruments are the major challenges to market growth.
Report infographic
-Market.webp)
Market dynamics
1 factors across 1 forceCapacity Expansions of Biopharmaceutical Plants to Propel the Demand for HPLC Systems
Biosimilars are gaining significant importance in oncology, autoimmune diseases, and rare diseases. The price advantage of biosimilars compared to biologics and the biosimilar substitution laws is boosting the demand for biosimilars. Several manufacturers are expanding their manufacturing facilities to meet the growing demand for biopharmaceuticals. The COVID-19 pandemic also resulted in the facility expansion of vaccine manufacturing plants. These capacity expansions from biopharmaceutical manufacturers and CDMOs will generate additional demand for biopharmaceutical manufacturing equipment and consumables, propelling the market’s growth. For instance, in December 2021, Biocon Ltd. (India) and Mylan N.V. (U.S.) announced their plans to combine their biosimilar businesses to create a larger company.
Table of contents
10 chapters · 105 sections · 251 pages · click to expandSegmental analysis
| Segment | Largest share (2023) | Fastest growth (2023–2030) |
|---|---|---|
| By Product | HPLC Systems | — |
By Product
- The HPLC systems segment is expected to account for the largest share of the HPLC market.
- The large market share of this segment is attributed to the availability of integrated and modular systems that can be used for various applications.
- Modular HPLC systems are stacked according to the need of the customers.
- Hence they are widely adopted for budget-constraint end users.
- Integrated systems have in-built modules that are preferred for applications requiring continuous analysis of samples.
- The Pharmaceutical & Biopharmaceutical Industries Segment Expected to Account for the Largest Share of the High-performance Liquid Chromatography Market
- The pharmaceutical & biopharmaceutical industries segment is expected to account for the largest share of the HPLC market.
- The large market share of this segment is attributed to the rise in the number of drugs in clinical studies, the high prevalence of infectious and non-infectious diseases, growing pressure on pharmaceutical companies to launch new therapies in the market, and the increasing investments in biopharmaceuticals.
Geographic analysis
North America
Largest shareIn 2023, North America is expected to account for the largest share of the global HPLC market. North America’s major market share is attributed to rising investments in pharmaceutical R&D, increased sales of pharmaceuticals, stringent environmental policies for monitoring pesticide & industrial chemical degrades, well-developed research infrastructure, and the presence of key market players in the region. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), in 2021, North America accounted for 49.1% of global pharmaceutical sales. North America to Dominate the Market in 2023
Competitive landscape
- Waters Corporation
- Shimadzu Corporation
- Danaher Corporation
- Bruker Corporation
- Merck KGaA
- Agilent Technologies, Inc.
- PerkinElmer, Inc.
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories, Inc.
- Sartorius AG
- Gilson, Inc.
- Tosoh Corporation
- Hitachi, Ltd.
- JASCO Corporation
Frequently asked questions
This study covers various HPLC systems, consumables, components & accessories, and software & services offered by key companies for clinical research, diagnostics, and forensics in pharmaceutical & biopharmaceutical companies, research institutes & academics, food & beverage companies and others.
Cite this report
Meticulous Research. (2023). High-performance Liquid Chromatography (HPLC) Market - Global Opportunity Analysis and Industry Forecast (2023-2030) (Report No. MRHC - 104711). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/high-performance-liquid-chromatography-market-5395